CDKN2B-AS1 and malignant colon neoplasm: According to Sun et al., colorectal cancer patients with a high level of ANRIL also expressed a higher level of VEGF-C, VEGFR-3, and LYVE-1, suggesting that ANRIL may act as a driver for lymphangiogenesis in colon cancer.